Mesulam Center for Cognitive Neurology and Alzheimer's Disease
Chicago, Illinois, 60611, United States
NCT Number: NCT05477862
Clinically Designed Improvisatory Music (CDIM) is a form of improvised music based on calm-inducing sound parameters which brought relief to our cohort of neurology patients. As a direct sound-based approach, CDIM does not rely on autobiographical memory and may have wider applicability and generalizability. We wish to examine if CDIM decreases anxiety in 15 cognitively healthy individuals and 15 Alzheimer Disease patients with anxiety (AD-A).
Interested in participating?
Request Info55 year–100 year
All sexes
Interventional
Not applicable
Chicago, Illinois, 60611, United States
The goal of this study is to identify the neural mechanisms of induced calmness through live clinically designed improvisatory music (CDIM) in cognitively healthy individuals and persons with Alzheimer's dementia suffering from agitation. This study is novel as most music interventions for dementia use familiar music and the underlying neural mechanism of calmness induced by music is not well known. We plan to investigate changes in 3 major large-scale brain networks using functional magnetic resonance imaging (fMRI). The major questions we plan to answer are as follows: 1. How does improvisatory music change the connectivity within brain emotion related networks in neurotypical individuals? 2. Does improvisatory music induce a state of calmness in individuals with Alzheimer's dementia and how? Based on objective evidence provided by this study we can justify further usage of music for patients with Alzheimer's, in particular, in the form of improvisation.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Cognitively healthy control participants evaluated through the Northwestern Mesulam Center. BAI > 8.
Exclusion criteria
hearing loss
This group will similarly be recruited through the Mesulam Center. All individuals recruited by the research Core at the center are well characterized tests standardized across all NIH funded Alzheimer Centers across the nation. Individuals with mild to moderate neurocognitive disorder due to AD will have an MMSE greater than >15 and Clinical Dementia Rating (CDR) between 0.5 and 2.. They will also have a history of neurocognitive-related agitation/anxiety, and a Beck Anxiety Index (BAI) or Rating for Anxiety in Dementia (RAID) greater than 8, suggestive of at least a mild level of anxiety.
Exclusion criteria
MMSE<15, CDR>2, hearing loss
Clinically Designed Improvisatory Music (CDIM) is a form of improvised music based on calm-inducing sound parameters which brought relief to our cohort of neurology patients.
Time frame: Through study completion (3 years)
Change in NPI (NPI-2 minus NPI-1)
Time frame: Through study completion (3 years)
Change in BAI (BAI-2 minus BAI-1)
Time frame: Through study completion (3 years)
Change in SBP (SBP-2 minus SBP-1)
Time frame: Through study completion (3 years)
Change in HR (HR-2 minus HR-1)
Time frame: Through study completion (3 years)
Change in RR (RR-2 minus RR-1)
Time frame: Through study completion (3 years)
Change in SC (SC-2 minus SC-1)
Time frame: Through study completion (3 years)
Functional Connectivity within three resting state networks: Change in Default Network (DN), Change in Salience Network (SN), and Change in Reward Network (RN).
Northwestern University
Other
Neural Mechanisms of Induced Calmness After Listening to Improvisatory Music: An Investigation for Healthy Individuals and Persons With Alzheimer's Dementia
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05543681
Aberrant Motor Behavior in Dementia, Aggression
Maitland, Florida, United States
View Trial DetailsNCT04075435
Aberrant Motor Behavior in Dementia, Agitation,Psychomotor
Belmont, Massachusetts, United States
View Trial DetailsNCT06940687
Alzheimer Disease, Anxiety Disorders
New Haven, Connecticut, United States
View Trial DetailsNCT07602283
Alzheimer Disease, Anxiety Disorders
New Haven, Connecticut, United States
View Trial Details